The following information was accurate at the time of posting, but may be superseded by subsequent disclosure.
December 23, 2008
Tekmira Partner Alnylam Files First IND for an RNAi Therapeutic Utilizing SNALP
November 13, 2008
Tekmira Announces Third Quarter 2008 Operating Results
November 10, 2008
Tekmira Conference Call Advisory
October 22, 2008
Tekmira Announces Presentation of Data Using SNALP RNAi Delivery Technology
September 29, 2008
Tekmira Expands Executive Management Team
September 8, 2008
Tekmira Collaborator National Cancer Institute Presents Data at Liver Cancer Conference
August 26, 2008
Tekmira Publishes Research that Addresses Critical Issue in the RNAi Field
August 14, 2008
Tekmira Announces Second Quarter 2008 Operating Results
August 13, 2008
Tekmira Announces RNAi Research Collaboration with Bristol-Myers Squibb
August 11, 2008
Tekmira Conference Call Advisory
August 6, 2008
Tekmira Provides Progress Update on Alnylam Collaboration
July 21, 2008
Tekmira Selects Two Products for Clinical Development in 2009
June 1, 2008
Tekmira and Protiva Announce Completion of Business Combination
May 28, 2008
Tekmira Shareholders Approve Business Combination
May 15, 2008
Tekmira Amends its Share Option Plan
May 14, 2008
Tekmira Releases First Quarter 2008 Operating Results
May 6, 2008
Tekmira Appoints Dr. Bruskin to Board
March 30, 2008
Tekmira and Protiva Announce Business Combination
March 30, 2008
Tekmira Releases 2007 Audited Results
March 28, 2008
Tekmira Presents Data at International RNAi Conference